Puma Biotechnology Inc (NASDAQ: PBYI) Stock Information | RedChip

Puma Biotechnology Inc (NASDAQ: PBYI) Listen to this Section


$2.70
+0.0500 ( +1.89% ) 380.0K

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

Market Data


Open


$2.70

Previous close


$2.65

Volume


380.0K

Market cap


$132.18M

Day range


$2.65 - $2.78

52 week range


$2.13 - $7.73

Insider Ownership Transactions

Total Amount Purchased: -90,436.00 | $ -244,177.20

Date Type Amount Purchased Purchaser
2024-01-05 Sale -41396.00 AUERBACH ALAN H
2024-01-05 Sale -15682.00 NOUGUES MAXIMO F
2024-01-05 Sale -8358.00 HUNT DOUGLAS M
2023-11-09 Sale -25000.00 MILLER MICHAEL PATRICK

SEC Fillings


Form Type Description Pages Date
ars Annual reports 1 Apr 26, 2024
8-k 8K-related 14 Mar 19, 2024
4 Insider transactions 1 Mar 19, 2024
8-k 8K-related 17 Feb 29, 2024
10-k Annual reports 96 Feb 29, 2024
4 Insider transactions 1 Feb 14, 2024
4 Insider transactions 1 Feb 14, 2024
4 Insider transactions 1 Feb 14, 2024
4 Insider transactions 1 Feb 14, 2024
4 Insider transactions 1 Feb 14, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.